BioSpace News Archive

Amicus Therapeutics, a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, announced financial results for the full year ended December 31, 2020.

Satsuma Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced that it has agreed to sell 14,084,507 shares of its common stock to certain institutional investors in a private investment in public equity financing.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the fourth quarter and year ended December 31, 2020.

At a virtual meeting with the investment community, Viatris Inc. will outline how the company expects to lead as a new kind of healthcare company with a unique and differentiated business model, high-quality operational platform and clear focus on ensuring its sustainability priorities and financial commitments are met.

Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang , M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences:

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced that IMV’s executive management team will be participating at the H.C. Wainwright Global Life Sciences Conference which will be held virtually on March 9-10.

Dr. Biller Brings More Than 30 Years of Experience Discovering and Advancing Novel Molecules, Most Recently as Chief Scientific Officer at Agios Pharmaceuticals

Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, announced today it is providing pumps, valves and seals to Pfizer to support production of its COVID-19 vaccine.

Fact.MR, a global research & consulting firm, in their latest edition of the report, anticipated that the acute pyelonephritis treatment market is projected to foresee a higher growth pace in 2021 and beyond.

Fact.MR, a global research & consulting firm, in their latest edition of the report, anticipated that the micro-bypass systems market will be experiencing steady growth pace, since the market is still in its initial phase. A rise in cases of aniridia along with other iris deficiencies in the general population are surging highly in geriatric patients.